• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/28/25 8:00:10 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email
    mlab20250527_8k.htm
    false 0000724004 0000724004 2025-05-28 2025-05-28


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549   
     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
     
    Date of Report (Date of earliest event reported): May 28, 2025
     
     
    MESA LABORATORIES, INC.
    (Exact name of registrant as specified in its charter)
     
     
    Colorado
    (State or other jurisdiction of
    incorporation)
    0-11740
    (Commission File Number)
    84-0872291
    (I.R.S. Employer
    Identification No.)
     
    12100 WEST SIXTH AVENUE,
    LAKEWOOD, Colorado
    (Address of principal executive offices)
     
    80228
    (Zip Code)
     
    Registrant’s telephone number, including area code: 303-987-8000
     
    Not Applicable
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered under Section 12(b) of the Act:
     
    Title of each class
     
    Trading Symbol
     
    Name of each exchange on which
    registered
     
             
    Common Stock, no par value
     
    MLAB
     
    The Nasdaq Stock Market LLC
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
     


     

     
     
    ITEM 2.02  RESULTS OF OPERATIONS AND FINANCIAL CONDITION
     
    On May 28, 2025, Mesa Laboratories, Inc. issued a press release relating to its results for the three and twelve months ended March 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1.
     
    The information furnished in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.
     
    ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
     
    (d)
    Exhibits:
     
     
    99.1
    Press release dated May 28, 2025.
     
    104
    Cover Page Interactive Data File (embedded withing the Inline XBRL document)
     
     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    DATE: May 28, 2025
     
    Mesa Laboratories, Inc.
    (Registrant)
     
     
     
     
     
     
     
     
     
     
    BY:
    /s/ Gary M. Owens
     
     
     
    Gary M. Owens
     
     
     
    President and Chief Executive Officer
     
     
     
    Get the next $MLAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    SEC Filings

    See more
    • Mesa Laboratories Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      6/6/25 3:00:33 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-K filed by Mesa Laboratories Inc.

      10-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:01:28 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:00:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on Mesa Laboratories with a new price target

      Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

      8/28/24 7:48:06 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

      1/4/24 8:29:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO Sakys John covered exercise/tax liability with 454 shares and exercised 1,036 shares at a strike of $95.82, increasing direct ownership by 4% to 15,044 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      6/25/25 9:14:30 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SVP Operations Archbold Brian David exercised 844 shares at a strike of $95.82 and covered exercise/tax liability with 385 shares, increasing direct ownership by 24% to 2,407 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      6/25/25 9:05:08 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • President and CEO Owens Gary M exercised 3,301 shares at a strike of $95.82 and covered exercise/tax liability with 1,445 shares, increasing direct ownership by 4% to 52,577 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      6/24/25 10:12:48 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials